Target General Infomation
Target ID
T16128
Former ID
TTDI02076
Target Name
Gastrin
Gene Name
GAST
Synonyms
G14; G17; G34; G52; G6; Gastrin6; GAST
Target Type
Clinical Trial
Disease Gastric cancer [ICD9: 151; ICD10: C16]
Function
Gastrin stimulates the stomach mucosa to produce and secrete hydrochloric acid and the pancreas to secrete its digestive enzymes. It also stimulates smooth muscle contraction and increases blood circulation and water secretion in the stomach and intestine.
BioChemical Class
Gastrin cholecystokinin
UniProt ID
Sequence
MQRLCVYVLIFALALAAFSEASWKPRSQQPDAPLGTGANRDLELPWLEQQGPASHHRRQL
GPQGPPHLVADPSKKQGPWLEEEEEAYGWMDFGRRSAEDEN
Drugs and Mode of Action
Drug(s) G17DT Drug Info Phase 3 Gastric cancer [524725]
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM)
TEP EXP Info
Pathways
KEGG Pathway Gastric acid secretion
PANTHER Pathway CCKR signaling map ST
PathWhiz Pathway Gastric Acid Production
Reactome G alpha (q) signalling events
Gastrin-CREB signalling pathway via PKC and MAPK
WikiPathways Gastrin-CREB signalling pathway via PKC and MAPK
Secretion of Hydrochloric Acid in Parietal Cells
Gastric acid production
GPCR downstream signaling
References
Ref 524725ClinicalTrials.gov (NCT02118077) Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer. U.S. National Institutes of Health.
Ref 528685G17DT: an antigastrin immunogen for the treatment of gastrointestinal malignancy. Expert Opin Biol Ther. 2007 Mar;7(3):397-404.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.